[Incidence and mortality of cervical cancer in China, 2014]

Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):241-246. doi: 10.3760/cma.j.issn.0253-3766.2018.04.001.
[Article in Chinese]

Abstract

Objective: To estimate the incidence and mortality of cervical cancer in China based on the cancer registry data in 2014, collected by the National Central Cancer Registry (NCCR). Methods: There were 449 cancer registries submitted cervical cancer incidence and deaths in 2014 to NCCR. After evaluating the data quality, 339 registries' data were accepted for analysis and stratified by areas (urban/rural) and age group. Combined with data on national population in 2014, the nationwide incidence and mortality of cervical cancer were estimated. Chinese population census in 2000 and Segi's population were used for age-standardized incidence/mortality rates. Results: Qualified 339 cancer registries covered a total of 288 243 347 populations (144 061 915 in urban and 144 181 432 in rural areas). The percentage of morphologically verified cases and death certificate-only cases were 86.07% and 1.01%, respectively. The mortality to incidence ratio was 0.30. The estimates of new cases were about 102 000 in China in 2014, with a crude incidence rate of 15.30/100 000. The age-standardized incidence rates by China standard population (ASR China) and world standard population (ASR world) of cervical cancer were 11.57/100 000 and 10.61/100 000, respectively. Cumulative incidence rate of cervical cancer in China was 1.11%. The crude and ASR China incidence rates in urban areas were 15.27/100 000 and 11.16/100 000, respectively, whereas those were 15.34/100 000 and 12.14/100 000 in rural areas. The estimates of cervical cancer deaths were about 30 400 in China in 2014, with a crude mortality rate of 4.57/100 000. The ASR China and ASR world mortality rates were 3.12/100 000 and 2.98/100 000, respectively, with a cumulative mortality rate (0-74 years old) of 0.33%. The crude and ASR China mortality rates were 4.44/100 000 and 2.92/100 000 in urban areas, respectively, whereas those were 4.72/100 000 and 3.39/100 000 in rural areas. Conclusions: There is still a heavy burden of cervical cancer in China. The burden and patterns of cervical cancer shows different characters of urban and rural people. Prevention and control strategies should be implemented referring to local status.

目的: 分析全国肿瘤登记中心收集的登记资料,估计2014年全国女性子宫颈癌的发病和死亡情况。 方法: 对2017年全国肿瘤登记中心449个登记处上报的2014年肿瘤登记数据进行评估,其中339个肿瘤登记处的数据符合入选标准,按城乡和年龄分层,结合2014年全国人口数据,估计全国女性子宫颈癌的发病和死亡情况。中国人口标化率(中标率)采用2000年全国人口普查的标准人口年龄构成,世界人口标化率(世标率)采用Segi′s标准人口年龄构成。 结果: 2014年339个肿瘤登记地区覆盖人口为288 243 347人(城市144 061 915人,农村114 181 432人)。子宫颈癌病理诊断比例为86.07%,只有死亡证明书比例为1.01%,死亡发病比为0.30。估计全国新发子宫颈癌病例数为10.20万例,发病率为15.30/10万,中标发病率为11.57/10万,世标发病率为10.61/10万,累积发病率(0~74岁)为1.11%。城市地区发病率为15.27/10万,中标发病率为11.16/10万;农村地区发病率为15.34/10万,中标发病率为12.14/10万。估计全国子宫颈癌死亡病例数约为3.04万例,死亡率为4.57/10万,中标死亡率为3.12/10万,世标死亡率为2.98/10万,累积死亡率(0~74岁)为0.33%。城市地区死亡率为4.44/10万,中标死亡率2.92/10万;农村地区恶性肿瘤死亡率为4.72/10万,中标死亡率为3.39/10万。 结论: 子宫颈癌是威胁我国女性健康的主要恶性肿瘤之一,且在城乡地区存在明显差异,应根据实际情况制订相应的子宫颈癌防治措施。.

Keywords: Cervical neoplasms; China; Incidence; Mortality.

MeSH terms

  • China / epidemiology
  • Female
  • Humans
  • Incidence
  • Registries / statistics & numerical data
  • Rural Population / statistics & numerical data
  • Urban Population / statistics & numerical data
  • Uterine Cervical Neoplasms / epidemiology*
  • Uterine Cervical Neoplasms / mortality